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Abstract The black-eyed pea trypsin and chymotrypsin inhib-
itor (BTCI) is a member of the Bowman-Birk protease inhibitor 
(BBI) family. The three-dimensional model of the BTCI-
chymotrypsin complex was built based on the homology to 
Bowman-Birk inhibitors with known structures. An extensive 
theoretical and experimental study of these known structures has 
been performed. The model confirms the ideas about Bowman-
Birk inhibitor structure-function relations and agrees well with 
our experimental data (circular dichroism, IR and light 
scattering). The electrostatic potentials at the enzyme-inhibitor 
contact surface reveal a pattern of complementary electrostatic 
potentials from which mutations can be inferred that could give 
these inhibitors an altered specificity. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
Plant protease inhibitors are frequently found in Legumino-
sae seeds. Most are proteins of low molecular weight that 
inhibit trypsin and/or chymotrypsin [1]. Their physiological 
significance in plants has been extensively investigated but 
has not yet been fully explained. 
Plant protease inhibitors are protective agents that are part 
of the arsenal of defence mechanisms that plants use to pro-
tect against attack by microoganisms, and insects. These sub-
stances are also involved in the protection of the seeds against 
environmental hazards during the initial phases of germina-
tion and in establishment of the seedling [2], 
There is accumulated evidence that consumption of seeds 
containing protease inhibitors lowers the incidence of breast, 
colon, prostatic, oral, and pharyngeal cancers [3]. Several 
studies have been performed which show that the soybean-
derived Bowman-Birk inhibitor can prevent carcinogenesis in 
vivo and malignant transformation in vitro [4,5]. 
Bowman-Birk double-headed protease inhibitors have mo-
lecular weights ranging from 7 to 10 kDa and have a high 
disulphide bond content. They have two independent, non-
overlapping sites for trypsin and chymotrypsin inhibition, re-
spectively [1]. 
Black-eyed pea trypsin and chymotrypsin inhibitor (BTCI) 
was isolated and purified to homogeneity from Vigna ungui-
culata (L) Walp seeds (cowpea, cv. Seridó). These cowpea 
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beans provide the main food protein source for most of the 
North-Eastern Brazilian population. BTCI is a single poly-
peptide chain of 83 residues [6]. Its amino acid sequence 
was reported by Morhy and Ventura [7]. The sites Lys26-
Ser27 and Phe53-Ser54 in BTCI inhibit trypsin and chymo-
trypsin, respectively. 
The three-dimensional structures of two members of the 
BBI family, a classical BBI from soybeans and the Bow-
man-Birk-type protease inhibitor, have been studied by X-
ray crystallography [8], and NMR [9]. The coordinates are 
available from the PDB [10] (PDB id = 1BBI and 1PI2, respec-
tively). An analysis of 1BBI and its complex with trypsin has 
been reported [11]. The conformation of the free and com-
plexed inhibitors are quite similar. 
The loops containing the inhibition sites are very exposed 
and thus easily accessible to proteolytic enzymes. Several 
highly conserved residues seem important for fixing the con-
formation of the inhibition loop in a conformation that allows 
the inhibitors to bind very tightly to the proteases. The stabil-
ity and the maintenance of the active conformation of all BBI-
like inhibitors are mainly attributed to a large number of 
(conserved) disulphide bridges [12]. 
A routine verification of the correctness of the two known 
BBI structures seemed to indicate that these molecules were 
not solved correctly. The core of the molecules is far too 
hydrophilic, and the protein surface is far too hydrophobic. 
However, analysis of the full crystal packing showed that 
most of hydrophobic part of the surface is involved in crystal 
contacts. The experimental work about BTCI (light scatter-
ing) indicates that the molecule is oligomeric in solution. 
We propose 3-D models for BTCI and a BTCI-oc-chymo-
trypsin complex. These models are built based on the homol-
ogy of BTCI with the Bowman-Birk inhibitors for which the 
structures are known. The models are discussed in view of 
experimental data obtained from light scattering [13], CD 
and IR spectroscopy [14,15], etc. The models are presently 
guiding protein engineering experiments aimed at alteration 
of the inhibitor stability and specificity in order to obtain 
inhibitors that can aid plant defence. 
2. Materials and methods 
2.1. Modelling BTCI 
Multiple sequence alignments were performed using the PILEUP 
program in the Genetics Computer Group (GCG) software package. 
The three-dimensional structure of BTCI has been modelled on the 
basis of the coordinates of the NMR structure [9] and X-ray crystal 
structure [8] of homologous inhibitors and the sequence alignment 
shown in Fig. 1. Molecular modelling and molecular mechanics 
were done using INSIGHT II, with Discover (Biosym Technologies, 
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San Diego, 1991) and WHAT IF [16], on Silicon Graphics 4D70GT 
and INDIGO ELAN workstations. 
Models built with WHAT IF were obtained using the protocol 
described before [17]. This protocol relies heavily on position-specific 
rotamer distributions [18]. Models built with INSIGHT II were con-
structed using the HOMOLOGY module of this package. Where 
these two models disagreed, manual decisions were made based on 
analyses using Procheck [19] and the structure verification options of 
WHAT IF. 
2.2. Modelling the BTCI-a-chymotrypsin complex 
The BTCI-a-chymotrypsin complex has been modelled using the 
homology with the complex of turkey ovomucoide inhibitor third 
domain (OMTKY3) for which the coordinates were determined by 
X-ray crystallography [20] (PDB id=lCHO). 
The inhibitor was docked in the enzyme by superimposing the 
BTCI loop Thr-42-Phe43-Ser44-Ile45 onto the OMTKY3 residues 
Thr-17-Leul8-Serl9-Tyr20. The side chains of the binding ß-hairpin 
of BTCI were modelled in agreement with the corresponding side 
chains of residues in the binding loop of OMTKY3. Only minor 
modifications were needed to avoid Van der Waals clashes. Standard 
rotamer libraries [21] were used to guide these (small) manual side 
chain modifications. 
This initial complex was energy minimised using Discover. In the 
minimisation procedure only those residues were incorporated that 
have at least one atom within 5 A of a residue that is part of the 
active site. This was done to avoid prohibitive CPU time require-
ments. Distance constraints were placed between pairs of atoms at 
the complex interface that are known to be essential for proper posi-
tioning of the inhibitor in the protease active site. These constraints 
mainly fix hydrogen bonds between the BTCI backbone (Phe-43) and 
the catalytic triad, and maintain the proper orientation of the active 
site residues. Energy minimisation was done until the maximum de-
rivative of the energy with respect to the atomic positions was less 
than 0.001 kcal/mol/A. The molecular dynamics simulation was run at 
500 K in vacuum to avoid restraining the molecule to a local mini-
mum with high energy. The conformation during this molecular dy-
namics run that had the lowest potential energy was energy minimised 
(using a conjugate gradient algorithm) to converge below 0.0001 kcal/ 
mol/A. 
2.3. Analysis of the interface 
A Connolly-type surface [22] was generated with INSIGHT II using 
a water probe radius of 1.4 A. The electrostatic potential was gener-
ated at neutral pH using the program GRASP [23]. Calculations were 
done simulating an aqueous solution with an ionic strength of zero 
and dielectric constants of 80 and 2 for solvent and protein respec-
tively. The electrostatic potential is interpolated on a solvent-accessi-
ble surface. The latter was obtained using a probe radius of 1.6 A to 
represent a water molecule. All calculations were performed at 300 K. 
The positive and negative potentials are contoured at 2 kcal/mol/A 
and —2 kcal/mol/A respectively. 
3. Results and discussion 
3.1. Sequence comparisons 
The multiple sequence alignment of several representative 
inhibitors from the Bowman-Birk family, is shown in Fig. 1. 
There is a high level of sequence identity throughout the 
whole family and the cysteine bridging pattern is entirely con-
served. The residues involved in inhibition of trypsin are iden-
tical in BTCI and IBBI, and highly conserved in 1PI2. There 
is a remarkably high conservation in the distribution of polar 
and non-polar residues throughout the molecules, including 
the chymotrypsin inhibition sites. 
3.2. The BTCI model 
Fig. 2 shows the 3-D model of BTCI with the two inhibitor 
loops indicated. Phe-43 is the key residue in the a-chymotryp-
tic inhibition site and Lys-16 in the trypsin inhibition site. 
Phe-43 is substituted by a leucine in IBBI molecule. Both 
inhibition sites are located in the tip of the corresponding 
ß-hairpin. 
The packing quality control option [24] of the WHAT IF 
program indicated that the BTCI model had some unusual 
structural features: aromatic residues are solvent exposed, 
and several hydrophilic residues are buried. However, this is 
also the case in the experimentally determined structures that 
were used as templates for the modelling. 
The NMR structure data presented by Werner and 
Wemmer [9] indicated that many NOEs are observed inside 
the ß-hairpins that contain the inhibition sites, but very few in 
the rest of the molecule. This indicates that these two ß-hair-
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Fig. 1. Alignment of representative Bowman-Birk-type protease inhibitors. Asterisks indicate the interaction sites for trypsin and chymotrypsin. 
The last sequence represents the BTCI. BBl_SOYBN (Glycine max), BB3_DOLAX (Dolichos axillaris), IBBI (Glycine max), 1PI2 (Glycine 
max), BB1_PHAAN (Phaseolus angularis), BB2_SOYBN (Glycine max), BB3_SOYBN (Glycine max), BB4_DOLAX (Dolichos axillaris), IBB_ 
PHALU (Phaseolus lunatus), IBB_VIGUN (Vigna unguiculata). 
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Fig. 2. Model of the 3-D structure of BTCI from Vigna unguiculata. The colours in the backbone ribbon indicate which parts of the structure 
are based on a large (blue or pink) or a small (yellow) number of observed NOEs in the IBBI structure. No long distance NOEs were observed 
for residues 1-6 and 64-71; only a few long distance NOEs were observed in the inter domain region [9]. 
pins are probably determined with high reliability, but their 
relative orientation, and the residues in the core of the mole-
cule are determined with less precision. In the crystal structure 
most of the hydrophobic residues that are surface exposed in 
the monomer are buried due to crystal contacts. The unusual 
amino acid distribution makes most tools commonly used for 
model or structure verification useless. We therefore resorted 
to extensive experimental verification of the models. 
3.3. Experimental model verification 
The secondary structure content and several aspects of the 
surface of BTCI have been examined spectroscopically. Fluo-
rescence studies and spectroscopic solvent perturbation stud-
ies suggest that the aromatic residues in BTCI are indeed 
largely exposed to the solvent [25,26]. Experimental data on 
the accessibility of certain amino acid residues have been 
reported by Martin and Ventura [27]. They observed that 
the single tyrosine in BTCI has its ring in contact with the 
solvent, but the hydroxyl group buried in the core of the 
protein. Difference absorption spectrometry indicated that 
all three phenylalanines in BTCI are exposed to solvent [28]. 
All these characteristics are indeed observed in the BTCI 
model. 
The anomalous distribution of hydrophobic and hydro-
philic amino acids is thermodynamically not favourable if 
BTCI would be monomeric in solution. However, data ob-
tained by light scattering (in solutions with pH 7.0 and ionic 
strength 0.25 at 25°C) [13] showed that the self-associating 
system of BTCI could be approximated by a monomer-hex-
amer equilibrium mechanism. Better approximation was ob-
tained by using schemes of association with intermediate size 
oligomers: monomer-trimer-hexamer, monomer-dimer-trimer-
hexamer and monomer-dimer-tetramer-hexamer. These three 
models all fit equally well to the experimental data. This sug-
gests that BTCI molecules are in continuous equilibrium be-
tween monomers and several forms of multimers. The hydro-
phobic residues that are exposed to the solvent in the 
monomeric BTCI molecule can be buried in the multimers, 
in agreement with the self-association observed in the light 
scattering experiments. These data explain some of the more 
puzzling aspects of the BTCI model and the structures re-
ported by Werner and Wemmer [9] and Chen et al. [8] and 
indicate that the anomalous distribution of hydrophobic and 
hydrophilic residues is indicative of a functional aspect of 
these molecules rather than of an error in the model or in 
the structure determination. 
The model predicted in the present work also is in good 
agreement with available experimental data from circular di-
chroism and infrared spectroscopic studies on BTCI [29,15]. 
The far-UV CD spectrum of native BTCI exhibits a deep 
negative band at 201 nm and small positive ellipticity values 
at wavelengths above 218 nm. This is quite similar to poly-
peptides and proteins in constrained unordered conformation, 
including some protease inhibitors [30] and confirms that 
BTCI is a non-helical protein. The typical negative dichroic 
band at 201 nm represents mainly the contribution of disul-
phide groups [29]. This is in agreement with model com-
pounds such as NN-diacetyl-L-cystine bis-methylamide that 
have a transition of the disulphide bond resulting in a nega-
tive CD band at 199 nm [31]. The reduction of the disulphide 
bonds in BTCI by dithioerythritol (DTE) resulted in a marked 
increase of the negative band and a blue-shift from 201 to 199 
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Fig. 3. BTCI-a-chymotrypsin complex. A: The BTCI backbone is shown as a blue, yellow and pink ribbon, the protease backbone is shown as 
a white ribbon. Phe-43 is depicted in ball and stick representation. Ribbon colours as in Fig. 2; white ribbon: chymotrypsin. B: Active site of 
a-chymotrypsin (white) with a bound inhibitor (green). This figure illustrates how Phe-43 in BTCI is oriented relative to the catalytic triad, the 
substrate specificity pocket, the oxyanion hole and the non-specific substrate binding region. Hydrogen bonds between BTCI and chymotrypsin 
are dashed. 
nm. The position and the sign of the 199 nm peak correspond spectrum of BTCI in a solid film suggest the occurrence of the 
perfectly with the signal expected from the C-S-S-C dihedral unordered, antiparallel ß-strand and ß-turn structures [14]. 
angle [31]. The amide I—III and amide V regions in the IR The infrared spectrum in D 2 0 , shows prominent bands at 
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Fig. 4. Connolly surface of the BTCI:a-chymotrypsin complex. The inhibitor surface and ribbon colours as in Fig. 2 and protease surface is in 
white. A ball and stick model of the Phe-43 (white) is shown to aid with the identification of the active site pocket. 
1643 cm 1 and 1632 cm 1, indicative of unordered conforma-
tion (28%) and antiparallel ß-strands (32%), respectively [15]. 
3.4. BTCI-a-chymotrypsin complex 
One important goal of the present study is to provide a 
model for the interaction between oc-chymotrypsin and 
BTCI. Fig. 3A shows the model of this complex. The catalytic 
triad, the chymotrypsin active site and the inhibition loop are 
indicated in Fig. 3B. Even after energy minimisation the 
OMTKY3 and BTCI inhibitor loops display a remarkably 
similarity (the backbone RMS displacement after optimal 
superpositioning is 0.48 A). The conformation of the en-
zyme-inhibitor complex has a good steric arrangement for 
hydrogen bonding of interacting amino acids, as is shown in 
Fig. 3B. This apparent ease of the docking procedure strongly 
suggests that the inhibitor, the enzyme and the complex are 
modelled reasonably correctly. 
3.5. The active site 
The solvent-accessible surface [22] of the interface in the 
complex is presented in Fig. 4. The fit of Phe-43 in the oc-
chymotrypsin active site is remarkable. In the BTCI monomer 
the PI residue (Phe-43) is solvent exposed. The conformation 
of the P3-P3' loop agrees with the conformations that are 
proposed in several studies of enzyme-inhibitor complexes 
[9,32]. The primary recognition event occurs between the PI 
residue of the inhibitor and the SI pocket of the protease. 
Huber and Bode [33] have noted that the position and orien-
tation of the Ser-195 Ογ, relative to the scissile peptide car-
bonyl, are consistent with a minimum in free energy. It has 
been demonstrated that the structure of the serine protease 
inhibitor complex may be consistent with a 'locked conforma-
tion' [34]. A scheme illustrating BTCI according to this model 
is shown in Fig. 4 and Fig. 3B. The convex hydrophobic sur-
face of the ß-hairpin make most of the contacts. In the sub-
strate specificity pocket several direct hydrogen bonds are 
observed between the inhibitor and protease residues that 
surround the oxyanion hole. This includes the important ser-
ine in the SI pocket (Ser-189), which does not interfere with 
the binding of inhibitor [34]. Phe-43 in BTCI fills the mainly 
hydrophobic specificity pocket allowing tetrahedral intermedi-
ate formation by hydrogen bond interaction at the oxyanion 
hole. Details of this hydrogen bonding network are indicated 
in Fig. 3B. 
3.6. The electrostatic potential 
The electrostatic potential of the BTCI-a-chymotrypsin 
complex can be used to understand some of characteristics 
of the complex and can shed further light on the mechanism 
of inhibition. Fig. 5 shows electrostatic potentials around the 
interface of the complex. GRASP picture shows peculiar com-
plementarity of the localized electrostatic potential on active 
site of the enzyme and inhibitor. Complementarity seems to 
be more emphasized on the surface ring around the active site. 
The inhibitor and enzyme both have a net charge of +3, but 
they can nevertheless bind because of the presence of this 
localized charge complementarity. 
4. Conclusions 
Lacking an experimentally determined 3-D structure, we 
have built a model for BTCI, and a model for the active 
site area of oc-chymotrypsin. This model has the same anom-
alous distribution of hydrophobic and hydrophilic residues as 
observed in the experimentally determined BBI structures; the 
core is rather hydrophilic and the surface is very hydrophobic. 
However, experimental data on the location of aromatic res-
idues in BTCI made clear that this exposure of aromatic side 
chains to solvent only occurs in monomers, but BTCI is 
mainly observed as multimers in solution. In the BBI X-ray 
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Fig. 5. Molecular interface of the BTCI (left) and chymotrypsin 
(right) in vicinity of the active site. On the top is presented surface 
curvature: convex vertices are green and flat to concave are white 
to gray colored, respectively. In the middle is presented the surface 
to surface distance map. White color represents more proximal in-
terface distances, blue and red are color codes for increasingly dis-
tant surfaces. At the bottom is presented electrostatic surface poten-
tial. The surface is colored according to the local electrostatic 
potential, ranging from dark blue (most positive region) to deep red 
(most negative region). 
structure most hydrophobic surface residues are involved in 
crystal contacts. The same effects have previously been deter-
mined by Millar et al. [35] and Harry and Steiner [36]. They 
reported that the surface of BBI is likely to be non-polar with 
a tendency to self-associate. Bode and Huber [37] noted that it 
is quite common to find non-polar residues with relatively 
high solvent accessibilities in many of the small serine pro-
tease inhibitor families. 
Our models give insight into many structural aspects of the 
inhibitor and of the complex, including a good fit at the bind-
ing interface. The identification of the interaction surface in 
the complex, allows us to design serine protease inhibitors 
that can strengthen the plants defence potential against spe-
cific insects/parasites. The peculiar positive potential around 
the tip of the BTCI inhibition site interacts with the negative 
potential near the ot-chymotrypsin active site. This explains 
how two molecules with net positive charges can bind to 
each other and it opens the possibility to alter the specificity 
of BBIs without the need to make mutations in the inhibitor 
loop. 
The Bowman-Birk inhibitor will be synthesized and altered 
through recombinant DNA techniques in order to evaluate its 
potential as anticarcinogenic and seed protection agents. 
Moreover, the trypsin and chymotrypsin inhibitor genes 
from cowpea, and other legume seeds, are promising candi-
dates for engineering plants resistant against arthropod para-
sites in an economically and environmentally sensible way. 
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